Jan 9, 2018
Immunotherapies are a new class of drug that harnesses the potential of the body’s immune system to target and destroy tumours. The episode is about the rise of immunotherapies. In the episode we discuss: how the rise of immunotherapies in the past decade has had a transformative effect on the prospects for the treatment of patients with cancer; a brief history of immunotherapies; preclinical safety assessments of novel immunotherapies; assessing antibody binding using tissue cross-reactivity studies; before finally looking to the future for immunotherapies.
The original article this episode is based on was written by Edward Cribb. If you'd like to view the original article then follow the link below:
You can also download the original article pdf here: